SOBERANA, Cuba’s COVID-19 Vaccine Candidates: Dagmar García-Rivera PhD Director of Research, Finlay Vaccine Institute
On August 13, 2020, Cuba’s national regulatory agency, the Center for Quality Control of Medicines, Equipment and Medical Devices (CECMED), authorized clinical trials for SOBERANA 01—Cuba’s first vaccine candidate and the first from Latin America and the Caribbean. On August 24, parallel Phase I/II...
Sparad:
| I publikationen: | MEDICC Review |
|---|---|
| Huvudupphov: | |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
Medical Education Cooperation with Cuba
2020
|
| Ämnen: | |
| Länkar: | https://www.redalyc.org/articulo.oa?id=437565248013 https://www.redalyc.org/journal/4375/437565248013/ https://www.redalyc.org/journal/4375/437565248013/html/ https://www.redalyc.org/journal/4375/437565248013/437565248013.epub https://www.redalyc.org/journal/4375/437565248013/movil https://doi.org/10.37757/MR2020.V22.N4.11 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|